Biohit Oyj Series B | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,706.00
10,419.00
7,241.00
7,731.00
8,714.00
9,378
Total Accounts Receivable
7,347.00
523.00
997.00
1,991.00
1,959.00
2,026
Inventories
646.00
816.00
637.00
864.00
681.00
826
Other Current Assets
363.00
252.00
-
-
-
-
Total Current Assets
24,062.00
12,010.00
8,875.00
10,586.00
11,354.00
12,230
Net Property, Plant & Equipment
505.00
857.00
782.00
717.00
708.00
557
Total Investments and Advances
1,999.00
-
596.00
381.00
-
1
Long-Term Note Receivable
-
4.00
2.00
2.00
2.00
-
Intangible Assets
1,732.00
1,607.00
1,396.00
1,196.00
6,764.00
5,045
Total Assets
28,302.00
14,508.00
11,728.00
12,989.00
18,895.00
17,887
ST Debt & Current Portion LT Debt
384.00
256.00
128.00
-
17.00
Accounts Payable
341.00
529.00
326.00
979.00
414.00
Income Tax Payable
65.00
54.00
-
4.00
8.00
Other Current Liabilities
4,853.00
789.00
785.00
839.00
839.00
Total Current Liabilities
5,643.00
1,628.00
1,239.00
1,822.00
1,278.00
Long-Term Debt
-
-
-
-
59.00
Deferred Taxes
205.00
170.00
99.00
305.00
244.00
Other Liabilities
-
3.00
3.00
5.00
4.00
Total Liabilities
5,852.00
1,831.00
1,418.00
2,239.00
1,652.00
Common Equity (Total)
22,450.00
12,677.00
10,310.00
10,750.00
17,243.00
Total Shareholders' Equity
22,450.00
12,677.00
10,310.00
10,750.00
17,243.00
Total Equity
22,450.00
12,677.00
10,310.00
10,750.00
17,243.00
Liabilities & Shareholders' Equity
28,302.00
14,508.00
11,728.00
12,989.00
18,895.00

About Biohit Oyj

View Profile
Address
Laippatie 1
Helsinki UU 00880
Finland
Employees -
Website http://www.biohithealthcare.com
Updated 07/08/2019
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.